CAS:2156-56-1
MF:C2H3Cl2NaO2
MW:152.93
EINECS:218-461-3
저장 조건:불활성 분위기,2-8°C
What is of Sodium Dichloroacetate with cas 2156-56-1?
Sodium dichloroacetate (DCA) is a mitochondrial pyruvate dehydrogenase kinase inhibitor, and is an orally absorbable small molecular compound for MELAS syndrome, and children with congenital lactic acidosis and other diseases that are treated in the clinic. Recent studies had found that DCA acts as a potential vasoprotective agent by inhibiting PDK2 and reducing coronary endarterium proliferation. Further, DCA promotes brain regeneration after cerebral ischemia, which indicates that DCA might play an important role in VD.
사양
항목
|
사양
|
결과
|
|
모
|
백색 분말 또는 결정성 분말
|
확인
|
|
순도,%
|
≥99.5
|
99.99
|
|
녹는점 범위℃
|
64.0~67.0
|
확인
|
|
건조감량,%
|
≤0.5
|
0.030
|
|
수분%
|
≤0.5
|
0.047
|
사용법
나트륨 dichloroacetate 억제제의 미토콘드리아 pyruvate dehydrogenase kinase.
포장
25 킬로그램/드럼,9tons/20'container